A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides
| Status: | Active, not recruiting | 
|---|---|
| Conditions: | Cosmetic | 
| Therapuetic Areas: | Dermatology / Plastic Surgery | 
| Healthy: | No | 
| Age Range: | 18 - Any | 
| Updated: | 4/21/2016 | 
| Start Date: | October 2014 | 
| End Date: | April 2016 | 
This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial
rhytides (forehead lines, glabellar lines, lateral canthal lines [crow's feet lines]).
			rhytides (forehead lines, glabellar lines, lateral canthal lines [crow's feet lines]).
Inclusion Criteria:
- Moderate to severe forehead lines, glabellar lines, and crow's feet lines
- Willing to have facial photos taken
Exclusion Criteria:
- Prior exposure to botulinum toxin of any serotype for any indication
- Anticipated need for treatment with botulinum toxin of any serotype for any
indication during the study, other than study treatment
- Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral
sclerosis
- Any facial resurfacing laser or light treatment, microdermabrasion, or superficial
peels in the past 3 months
- Any medium depth or deep depth facial chemical peels; facial skin resurfacing; or
permanent facial make-up in the past 6 months
- Any nonpermanent soft tissue fillers, or treatment with oral retinoids in the past
year - Prior face lift, thread lift, eyebrow lift, or related procedures (eg, eyelid
and/or eyebrow surgery)
- Prior facial treatment with permanent soft tissue fillers, synthetic implants (eg,
Gore-Tex®), and/or fat transplantation
We found this trial at
    4
    sites
	Click here to add this to my saved trials
	Click here to add this to my saved trials
	Click here to add this to my saved trials